224 related articles for article (PubMed ID: 31418610)
1. Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
Figueras-Roca M; Sala-Puigdollers A; Alforja S; Torras J; Peraza-Nieves J; Zarranz-Ventura J; Adan Civera A; Molins B
Ocul Immunol Inflamm; 2019; 27(8):1203-1210. PubMed ID: 31418610
[No Abstract] [Full Text] [Related]
2. Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.
Figueras-Roca M; Sala-Puigdollers A; Zarranz-Ventura J; Alba-Linero C; Alforja S; Esquinas C; Molins B; Adán A
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1336-1343. PubMed ID: 30933261
[TBL] [Abstract][Full Text] [Related]
3. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Yu SY; Nam DH; Lee DY
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
[TBL] [Abstract][Full Text] [Related]
4. Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema.
Podkowinski D; Orlowski-Wimmer E; Zlabinger G; Pollreisz A; Mursch-Edlmayr AS; Mariacher S; Ring M; Bolz M
Acta Ophthalmol; 2020 Jun; 98(4):e407-e415. PubMed ID: 31736269
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
6. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
Lo Giudice G; Avarello A; Campana G; Galan A
Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
[TBL] [Abstract][Full Text] [Related]
7. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
8. Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.
Hillier RJ; Ojaimi E; Wong DT; Mak MYK; Berger AR; Kohly RP; Kertes PJ; Forooghian F; Boyd SR; Eng K; Altomare F; Giavedoni LR; Nisenbaum R; Muni RH
JAMA Ophthalmol; 2018 Apr; 136(4):382-388. PubMed ID: 29522144
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
[TBL] [Abstract][Full Text] [Related]
10. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
11. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
13. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.
Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K
Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656
[TBL] [Abstract][Full Text] [Related]
14. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
[TBL] [Abstract][Full Text] [Related]
15. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC
Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
[TBL] [Abstract][Full Text] [Related]
16. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography.
Mao J; Zhang S; Zheng Z; Deng X; Liu C; Chen Y; Zhao S; Zhang Y; Shen L
Acta Ophthalmol; 2022 Jun; 100(4):e891-e898. PubMed ID: 34403203
[TBL] [Abstract][Full Text] [Related]
17. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
18. Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
Felfeli T; Juncal VR; Hillier RJ; Mak MYK; Wong DT; Berger AR; Kohly RP; Kertes PJ; Eng KT; Boyd SR; Altomare F; Giavedoni LR; Muni RH
Am J Ophthalmol; 2019 Oct; 206():176-183. PubMed ID: 30959004
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
[TBL] [Abstract][Full Text] [Related]
20. Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema.
Shiraya T; Kato S; Araki F; Ueta T; Miyaji T; Yamaguchi T
PLoS One; 2017; 12(3):e0174340. PubMed ID: 28346545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
